HOME › DRUGS › ENCORAFENIB
ACTIVE SUBSTANCE / INN

ENCORAFENIB

Brand name(s): Braftovi, BRAFTOVI
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Melanoma;Colorectal Neoplasms
NDA210496
ACTIVE SUBSTANCE
Encorafenib
REGULATORS
FDA · EMA
SPONSORS / MAH
Pierre Fabre Medicament, ARRAY BIOPHARMA INC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BRAFTOVINDA210496ARRAY BIOPHARMA INCDiscontinued
BRAFTOVINDA210496ARRAY BIOPHARMA INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BraftoviPierre Fabre MedicamentAuthorised19/09/2018Melanoma;Colorectal Neoplasms

FULL INTELLIGENCE ON ENCORAFENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →